Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial

Jan B. Vermorken, Anke M E Claessen, Harm Van Tinteren, Helen E. Gall, Renate Ezinga, Sybren Meijer, Rik J. Scheper, Chris J L M Meijer, Elizabeth Bloemena, Janet H. Ransom, Michael G. Hanna, Herbert M. Pinedo

Research output: Contribution to journalArticlepeer-review

427 Scopus citations

Fingerprint

Dive into the research topics of 'Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences